Stock RSPI RESPIRERX PHARMACEUTICALS INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Chart RespireRx Pharmaceuticals Inc.

Equities

RSPI

US7612273059

Market Closed - OTC Markets
Other stock markets
 01:29:43 11/06/2024 am IST 		5-day change 1st Jan Change
0.0025 USD +25.00% Intraday chart for RespireRx Pharmaceuticals Inc. 0.00% +177.78%
10/04 RespireRx Pharmaceuticals Inc. announced that it has received $0.1 million in funding CI
20/03 RespireRx Pharmaceuticals Inc. Reports Publication of Preclinical Research Results Demonstrating the Ability of CX1739, its Lead Clinical AMPAkine, to Improve Bladder Function After Spinal Cord Injury CI
5d226ad.Bh0G0wdW99FS4yINOtUcLmhz5Z7W-6mi952cMMLgTs4.QC1fqWsHgbx_l1VdfJZRShtegvuhi9jIttv3BavZCqs_d1GDYiyUmzSFdw~25feb6f3ef44150b52450a406bc96747
  1. Stock Market
  2. Equities
  3. RSPI Stock
  4. Charts RespireRx Pharmaceuticals Inc.
  5. News Chart